HIV treatment Current Events | HIV treatment News | 7
|
| Page
7 of
38 |
756 Results |
|
|
|
Sort By:
Page Views | Date |
New Study Shows Benefit of Early Therapy in HIV-infected Infants
Antiretroviral therapy (ART) for infants born with HIV infection may be most effective when given in their first five months of life, according to a study published in the April 1 issue of The Journal of Infectious Diseases, now available online. view more (2006-03-09)
African HIV Subtypes Identified in Minnesota Population
Public health researchers in Minnesota recently identified 83 persons infected with subtypes of HIV-1 that are not common in the United States, according to a report published in the June 15 issue of The Journal of Infectious Diseases, now available online. view more (2005-05-31)
Spermicide Gel Could Increase Risk Of HIV-1 Infection
A common spermicide gel which has previously been proposed as a preventative agent against HIV-1 infection has been shown to be ineffective, according to authors of a study in this week's issue of THE LANCET-and could actually increase HIV-1 transmission if used frequently. Nonoxynol-9 is an inexpensive over-the-counter spermicide; laboratory... view more... (2002-09-25)
nvestment Level in HIV Prevention Programs Related to HIV Incidence in the United States
Researchers at Johns Hopkins Bloomberg School of Public Health conducted a historical analysis to examine the relationship between the Centers for Disease Control and Prevention's (CDC) HIV prevention budget and HIV incidence in the U.S. from 1978 to 2006. view more (2007-01-31)
Pneumococcal conjugate vaccines can improve the lives of HIV-infected children
An international team of experts has published the first comprehensive review of evidence on pneumococcal conjugate vaccination (PCV) for children with HIV infection. view more (2007-11-29)
HIV vaccine takes different tack to boosting immune response
esearchers at Baylor College of Medicine (BCM) in Houston have reason to believe their unorthodox vaccine could one day help to prevent or control HIV infection. view more (2006-01-03)
Pediatric HIV: Oral lesions are commonly associated with the disease
Across the globe, the presence of HIV is wide-spread. At the end of 2004, the United Nations HIV/AIDS program estimated that 2.5 million children under the age of 15 were affected worldwide. view more (2006-10-09)
NIAID describes challenges, prospects for an HIV vaccine
Events of the past year in HIV vaccine research have led some to question whether an effective HIV vaccine will ever be developed. In the August 28 edition of the New England Journal of Medicine, officials from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, examine the extraordinarily... view more... (2008-08-28)
HIV drug resistance risk in mothers reduced by combination of common drugs
New research from the University of Alabama at Birmingham (UAB) shows that adding a single dose of two common anti-HIV drugs can prevent HIV-positive pregnant women from developing resistance to an entire class of drugs, potentially improving future treatment options. view more (2007-11-12)
Tools for more accurate dosage of drugs against HIV/AIDS and malaria
A doctoral thesis presented at the Sahlgrenska Academy, University of Gothenburg, Sweden, shows that it is possible to describe and quantify the relationships between dose, concentration and effectiveness of several drugs against HIV/AIDS and malaria. The method may allow improved treatment and fewer undesired effects for patients with these... view more... (2009-03-06)
Drug Combo Against AIDS-Related Infections Also Prevents Malaria
A drug combination used to prevent pneumonia and opportunistic bacterial infection in persons with HIV/AIDS has unexpectedly been found to be highly effective at preventing malaria. view more (2005-10-19)
Higher HIV infection estimate shows need for routine screening, more funding for care
The Centers for Disease Control and Prevention (CDC) is expected soon to increase the estimate of new HIV infections in the United States by 40 percent. This highlights the need to make HIV testing a routine part of medical care and provide better funding to care for those who test positive, according to the HIV Medicine Association (HIVMA). view more (2008-08-04)
HIV infection requires an accomplice: B cells with special protein direct HIV to T cells
HIV infection of T cells requires activation of a molecule on the surface of B cells, a finding that reveals yet another pathway the virus uses in its insidious attack on the immune system. view more (2006-08-14)
Different HIV rates among gay men and straight people not fully explained by sexual behavior
Differences in sexual behaviours do not fully explain why the US HIV epidemic affects gay men so much more than straight men and women, claims research published ahead of print in the journal Sexually Transmitted Infections. view more (2007-09-14)
Focusing HIV treatment helps control concurrent hepatitis B infection
Prolonged use of highly active antiretroviral therapy (HAART) to treat people infected with both HIV and hepatitis B (HBV) helps to better control the hepatitis B infection and could delay or prevent liver complications. view more (2009-07-15)
Model of pre-exposure prophylaxis against HIV forecasts benefits, potential cost-effectiveness
For every two people who begin treatment for HIV infection globally, five others become newly infected. Therefore, preventing new HIV infections is the foremost strategy for ending the HIV/AIDS epidemic. view more (2009-02-10)
HIV persists in the gut despite long-term HIV therapy
Even with effective anti-HIV therapies, doctors still have not been able to eradicate the virus from infected individuals who are receiving such treatments, largely because of the persistence of HIV in hideouts known as viral reservoirs. view more (2008-02-14)
Gene therapy shows promise as weapon against HIV
A new UCLA AIDS Institute study has found that gene therapy can be developed as a safe and active technique to combat HIV. view more (2009-02-23)
Can periodontal disease act as a risk factor for HIV-1?
Today, during the 87th General Session of the International Association for Dental Research, convening at the Miami Beach Convention Center, a group of scientists from Nihon University (Tokyo, Japan) will present findings suggesting that periodontal disease could act as a risk factor for reactivating latent HIV-1 in affected individuals. view more (2009-04-03)
New protein target may advance design of HIV and cancer drugs
Using small molecules containing platinum, Virginia Commonwealth University Massey Cancer Center researchers have created a process to inhibit a class of proteins important in HIV and cancer. view more (2006-05-31)
|
|
| Page
7 of
38 |
756 Results |
|
|
|
Sort By:
Page Views | Date |
|
